#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A study of Pseudovax, molgramostim and tislelizumab combination therapy for patients with pseudomyxoma peritonei cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway

  • Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark France +8

  • Testing SAR442970 compared to placebo in adults with moderate to severe Crohn’s disease

    Recruiting

    2 1
    Investigated Drugs:
    Belgium Czechia France Germany Poland Spain

  • Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Denmark France Germany +5

  • Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Denmark France Germany Greece +3

  • Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer’s Disease over 72 weeks

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Italy The Netherlands Poland +2

  • Study of Atomoxetine to Reduce Freezing of Gait in Patients with Parkinson’s Disease During OFF-State

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of visugromab and nivolumab with or without docetaxel as second-line treatment for patients with metastatic non-squamous non-small cell lung cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    Germany Italy Poland Romania Spain

  • Long-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder

    Recruiting

    3 1 1
    Czechia Germany Greece Ireland Poland

  • Evaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark Finland France Germany +7